Tothill, N. F. H., Kulesa, C. A., Zhu, Z., Bardin, J., Cui, X., Everett, J., Feng, L., Golish, D., Gong, X., Hu, J., Jacobs, K., Jiang, Z., Walker, C. K., Jones, G., Li, Y., Martin, C. L., McCaughrean, M. J., Qin, W., Schein, M., Shang, Z., Siegel, P., Sun, B., Walsh, W., Yang, J., Wang, L., Weinreb, S., Xu, Z., Yan, J., Yuan, X., Zhang, X. -G., Ashley, M. C. B., Lawrence, J. S., Luong-Van, D., Storey, J. W. V., Yang, H., Zhou, X.. EDP Sciences; 2010. THz astrophysics from Dome A.

Degryse, S., De Bock, C. E., Verrills, N. M., Van Vlierberghe, P., Cools, J., Dun, M. D., Demeyer, S., Govaerts, I., Bornschein, S., Verbeke, D., Jacobs, K., Binos, S., Skerrett-Byrne, D. A., Murray, H. C.. Nature Publishing Group; 2018. Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.